Group Health Cooperative Logo Group Health Center for Health Studies

 skip navigation

site map  search  ghc.org    
         

Explore CHS

 
     Home  
     Research  
     Center Staff  
     Scientific Resources  
     The MacColl Institute  
 
 
  Community Health
and Evaluation
 
 
 
  GH's Dept of 
Preventive Care
 
     CHS Bibliography  
     News Releases  
     Events  
 Research Newsletter
     Career Opportunities  
     About CHS  
     Contact Us  
     Study Participants  
 
 

Cardiovascular Health

Study Examples | Key Publications | Intro

Heart disease, the leading cause of death in older adults, has long been a high priority for investigators at Group Health Center for Health Studies (CHS). Researchers interested in heart disease here keep finding new links between cardiovascular problems and genetic inheritance, health behaviors, and various medications such as antihypertensive drugs and hormone replacement therapy (HRT). These discoveries spring from well-designed studies that put Group Health’s extensive administrative and pharmacy databases to good use, along with telephone interviews with patients.

CHS scientists often collaborate with colleagues at the University of Washington (UW), the Fred Hutchinson Cancer Research Center (FHCRC), the University of Leiden in the Netherlands, and other institutions. These investigators’ findings have challenged conventional wisdom and changed standard practice in several areas. Examples include how to help prevent heart attacks, stroke, irregular heartbeats, and blood clots in deep veins; and how to treat people with high blood pressure as well as women during and after menopause.

"The goal of studying interactions between drugs and genes is to identify patients who may be especially susceptible to either the benefits or the risks of a drug therapy," says Bruce M. Psaty, MD, PhD, a senior investigator at CHS. "If these genetic variants can be identified and confirmed in additional studies, the application of this knowledge will help assure that each individual patient receives the safest and most effective therapies for him or her."

Study Examples | Key Publications | Intro

Top

 

 

"Medicines that will be used by millions of Americans for long periods of time are best evaluated in large long-term trials that begin as early as possible in the drug approval process. We also need additional post-marketing studies to assure that newly approved drugs are safe and effective in the populations that use them."

Bruce M. Psaty, MD, PhD, senior investigator at CHS

 

Major CHS Research Interests
           
 
site map  search  ghc.org    
Copyright 2008 Group Health Cooperative. Revised: May 31, 2006. Contact Us